Middlefield Sustainable Innovation & Health Dividend Fund

Fund Description

The Fund invests in a leading global innovative technology and healthcare companies in the public and private markets. This includes an investment in Sagard Healthcare Royalty Partners which acquires royalties, provides royalty-backed loans and invest directly in approved biopharmaceuticals, diagnostics and medical devices in return for a royalty on direct sales.

Key Reasons to Invest:

  • exposure to an actively managed fund which provides tax-efficient monthly distributions
  • a high conviction portfolio of companies focused on the innovation and healthcare industries, two sectors characterized by ongoing developments in technology
  • portfolio companies are selected with an emphasis on environmental, social and governance factors to complement rigorous fundamental analysis

SIH.UN 

Closing price  Ways To Invest Fact Sheet Prospectus (English) Prospectus (French) All Fund Documents

Fund Overview

  • Ticker/CUSIP:
    SIH.UN/86934T106
  • Inception Date:
    August 14, 2020
  • Monthly Distribution:
    $0.03333
  • Advisor:
    Middlefield Capital Corporation
  • Eligibility:
    RRSPs, RRIFs, DPSPs, RESPs and TFSAs
  • Management Fee:
    1.10%
  • Risk Rating:
    Not Rated
  • Exchange:
    Toronto Stock Exchange

Industry Advisor

Fund Managers

Headshot of Robert Lauzon
Robert F. Lauzon
Managing Director and Chief Investment Officer
Headshot of Robert Moffat
Robert Moffat
Portfolio Manager
Shane Obata
Portfolio Manager
Headshot of Mallika Verma
Mallika Verma
Investment and ESG Analyst

Performance

 
AS OF 1 MONTH 3 MONTHS 6 MONTHS YEAR-TO-DATE 1 YEAR 3 YEARS 5 YEARS 10 YEARS SINCE INCEPTION 2021 2020 2019 2018
December 31, 2022 -3.25% 9.95% 9.00% -13.59% -13.59% - - - 5.65% 24.33% - - -

Distributions

Total NAV & Distributions (since inception)  
Show More
RECORD DATE PAYMENT DATE PAYMENT AMOUNT
March 31, 2023 April 14, 2023 0.03333
February 28, 2023 March 15, 2023 0.03333
January 31, 2023 February 15, 2023 0.03333
December 31, 2022 January 13, 2023 0.03333
November 30, 2022 December 15, 2022 0.03333
October 31, 2022 November 15, 2022 0.03333
September 30, 2022 October 14, 2022 0.03333
August 31, 2022 September 15, 2022 0.03333
July 31, 2022 August 15, 2022 0.03333
June 30, 2022 July 15, 2022 0.03333

Fund Details

Sector Allocation (%)

As Of December 31, 2022
Healthcare 61.80%
Technology 21.70%
Utilities 8.30%
Real Estate 5.30%
Communication Services 2.90%

Geographic Allocation (%)

As Of December 31, 2022
Canada 4.90%
U.S. 95.10%
International 0.00%

Top 10 Holdings

1 Sagard Healthcare Royalty Partners 6.50%
2 Astrazeneca 5.50%
3 Abbvie Inc. 5.40%
4 AES Corporation 5.30%
5 Thermo Fisher Scientific Inc. 5.10%
6 Eli Lilly and Company 5.10%
7 UnitedHealth Group 4.90%
8 Pfizer Inc. 4.80%
9 Dexcom 4.70%
10 Visa Inc. 4.60%
Close
Subscribe to Our Insights!
Flyout Form